Publications by Year: 2012

2012
Carpenter D KG. Reputation and Public Administration. Public Administration Review. 2012;72 (1).
Shrank WH, Choudhry NK TMFMASSBTALJNMACAJK. Warnings without Guidance: Patient Responses to an FDA Warning about Ezetimibe. Medical Care. 2012;50 (6).
D C. Is Health Politics Different?. Annual Review of Political Science. 2012;15.
Carpenter D, Krause G. Reputation and Public Administration. Public Administration Review. 2012;72 (1) :26 - 32. Publisher's VersionAbstract
This article examines the application of organizational reputation to public administration. Organizational reputation is defined as a set of beliefs about an organization’s capacities, intentions, history, and mission that are embedded in a network of multiple audiences. The authors assert that the way in which organizational reputations are formed and subsequently cultivated is fundamental to understanding the role of public administration in a democracy. A review of the basic assumptions and empirical work on organizational reputation in the public sector identifies a series of stylized facts that extends our understanding of the functioning of public agencies. In particular, the authors examine the relationship between organizational reputation and bureaucratic autonomy.
Carpenter D, Chattopadhyay J, Moffitt S, Nall C. The Complications of Controlling Agency Time Discretion: FDA Deadlines and Postmarket Drug Safety. American Journal of Political Science. 2012. fdadeadlinesandsafety_ajps2012.pdf